JAK2抑制剂
| 英文名 | LY2784544 | CAS号 | 1229236-86-5 |
| 试剂别名 |
LY2784544;3-(4-Chloro-2-fluorobenzyl)-2-methyl-N-(5-methyl-1H-pyrazol-3-yl)-8-(morpholinomethyl)imidazo[1,2-b]pyridazin-6-amine;3-[(4-chloro-2-fluorophenyl)methyl]-2-methyl-N-(5-methyl-1H-pyrazol-3-yl)-8-(4-morpholinylmethyl)-Imidazo[1,2-b]pyridazin-6-amine;3-[(4-chloro-2-fluorophenyl)methyl]-2-methyl-N-(5-methyl-1H-pyrazol-3-yl)-8-(morpholin-4-ylmethyl)imidazo[1,2-b]pyridazin-6-amine;LY2784544;LY2874544;gandotinib;Gandotinib [USAN];LY-2784544;3-[(4-Chloro-2-fluorophenyl)methyl]-2-methyl-N-(5-methyl-1H-pyrazol-3-yl)-8-(4-morpholinylmethyl)imidazo[1,2-b]pyridazin-6-amine
|
分子式 | C23H25ClFN7O |
| 产品编号 | APEA4147 | 分子量 | 469.94 |
| MDL号 |
| 产品名称： | JAK2抑制剂 |
| 英文名称： | LY2784544 |
| 英文别名： | LY2784544;3-(4-Chloro-2-fluorobenzyl)-2-methyl-N-(5-methyl-1H-pyrazol-3-yl)-8-(morpholinomethyl)imidazo[1,2-b]pyridazin-6-amine;3-[(4-chloro-2-fluorophenyl)methyl]-2-methyl-N-(5-methyl-1H-pyrazol-3-yl)-8-(4-morpholinylmethyl)-Imidazo[1,2-b]pyridazin-6-amine;3-[(4-chloro-2-fluorophenyl)methyl]-2-methyl-N-(5-methyl-1H-pyrazol-3-yl)-8-(morpholin-4-ylmethyl)imidazo[1,2-b]pyridazin-6-amine;LY2784544;LY2874544;gandotinib;Gandotinib [USAN];LY-2784544;3-[(4-Chloro-2-fluorophenyl)methyl]-2-methyl-N-(5-methyl-1H-pyrazol-3-yl)-8-(4-morpholinylmethyl)imidazo[1,2-b]pyridazin-6-amine |
| 中文别名： | LY2784544盐酸巴多昔芬;3-(4-氯-2-氟苄基)-2-甲基-N-(3-甲基-1H-吡唑-5-基)-8-(吗啉甲基)咪唑并[1,2-b]吡嗪-6-胺;3-[(4-氯-2-氟苯基)甲基]-2-甲基-N-(5-甲基-1H-吡唑-3-基)-8-(4-吗啉甲基)咪唑并[1,2-B]哒嗪-6-胺;7-O-(三乙基硅)紫杉醇;LY2784544 抑制剂;盐酸巴多昔芬;3-[(4-氯-2-氟苯基)甲基]-2-甲基-N-(5-甲基-1H-吡唑-3-基)-8-(4-吗啉甲基)咪唑并[1,2-b]哒嗪-6-胺 |
| CAS No.： | 1229236-86-5 |
| 分子式： | C23H25CLFN7O |
| 分子量： | 469.94 |
| 危险品级别： | |
| HS符号： | |
| 危害声明： |
